Treatment Persistence and Compliance with Medications for Chronic Obstructive Pulmonary Disease

Canadian Respiratory Journal. 2007;14(1):25-29 DOI 10.1155/2007/161652


Journal Homepage

Journal Title: Canadian Respiratory Journal

ISSN: 1198-2241 (Print); 1916-7245 (Online)

Publisher: Hindawi Limited

LCC Subject Category: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system

Country of publisher: United Kingdom

Language of fulltext: English

Full-text formats available: PDF, HTML, ePUB, XML



Joyce A Cramer (Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA)

Carole Bradley-Kennedy (Boehringer Ingelheim (Canada) Ltd, Burlington, Ontario, Canada)

Alissa Scalera (Pfizer Canada Inc, Kirkland, Quebec, Canada)


Blind peer review

Editorial Board

Instructions for authors

Time From Submission to Publication: 38 weeks


Abstract | Full Text

BACKGROUND AND OBJECTIVE: Inhaled beta-agonist, anticholinergic and glucocorticoid medications are used to treat asthma and chronic obstructive pulmonary disease (COPD). The present study assessed the patterns of persistence with the above mentioned inhaled medications.